HOME    SEARCH    ABOUT US    CONTACT US    HELP   
           
Rule: 24.174.524 Prev     Up     Next    
Rule Title: COLLABORATIVE PRACTICE AGREEMENT REQUIREMENTS
Add to My Favorites
Add to Favorites
Department: LABOR AND INDUSTRY
Chapter: BOARD OF PHARMACY
Subchapter: Licensing
 
Latest version of the adopted rule presented in Administrative Rules of Montana (ARM):

Printer Friendly Version

24.174.524    COLLABORATIVE PRACTICE AGREEMENT REQUIREMENTS

(1) A pharmacist engaged in collaborative practice must:

(a) maintain an executed written copy of the collaborative practice agreement at the pharmacy and any other location in which the practice is occurring; and

(b) make the agreement available for inspection by the board.

(2) The collaborative practice agreement must include:

(a) identification of the practitioner(s) and pharmacist(s) who are parties to the agreement;

(i) the practitioner as defined in 37-2-101, MCA, must be licensed in good standing in Montana;

(b) the types of decisions that the pharmacist is allowed to make;

(c)  a method for the practitioner to monitor compliance with the agreement and clinical outcomes and to intercede where necessary;

(d)  a provision that allows the practitioner to override a collaborative practice decision made by the pharmacist whenever the practitioner deems it necessary or appropriate;

(e)  a provision that allows either party to cancel the agreement by written notification;

(f)  an effective date;

(g) signatures of collaborating pharmacists and practitioners, or a representative from the medical practice or clinic that is authorized to represent its practitioners, who are party to the agreement, as well as dates of signing; and

(h)  a procedure for periodic review and renewal within a time frame that is clinically appropriate.

(3) Documentation of allowed pharmacist activities must be kept as part of the patient's permanent record and be readily available to other health care professionals providing care to the patient and who are authorized to receive it.  Documentation of allowed activities shall be considered protected health information.

(4) Collaborative practice agreements approved by an institutional committee such as the pharmacy and therapeutics committee and that will be used solely for patients while they are receiving care in the institution are exempt.

 

History: 37-7-201, MCA; IMP, 37-7-101, 37-7-201, MCA; NEW, 2002 MAR p. 794, Eff. 2/1/02; AMD, 2006 MAR p. 1615, Eff. 6/23/06; AMD, 2007 MAR p. 1936, Eff. 11/22/07; AMD, 2019 MAR p. 1633, Eff. 9/21/19; AMD, 2021 MAR p. 1671, Eff. 11/20/21.


 

 
MAR Notices Effective From Effective To History Notes
24-174-74 11/20/2021 Current History: 37-7-201, MCA; IMP, 37-7-101, 37-7-201, MCA; NEW, 2002 MAR p. 794, Eff. 2/1/02; AMD, 2006 MAR p. 1615, Eff. 6/23/06; AMD, 2007 MAR p. 1936, Eff. 11/22/07; AMD, 2019 MAR p. 1633, Eff. 9/21/19; AMD, 2021 MAR p. 1671, Eff. 11/20/21.
24-174-71 9/21/2019 11/20/2021 History: 37-7-201, MCA; IMP, 37-7-101, 37-7-201, MCA; NEW, 2002 MAR p. 794, Eff. 2/1/02; AMD, 2006 MAR p. 1615, Eff. 6/23/06; AMD, 2007 MAR p. 1936, Eff. 11/22/07; AMD, 2019 MAR p. 1633, Eff. 9/21/19.
24-174-56 11/22/2007 9/21/2019 History: 37-7-201, MCA; IMP, 37-7-101, 37-7-201, MCA; NEW, 2002 MAR p. 794, Eff. 2/1/02; AMD, 2006 MAR p. 1615, Eff. 6/23/06; AMD, 2007 MAR p. 1936, Eff. 11/22/07.
6/23/2006 11/22/2007 History: 37-7-201, MCA; IMP, 37-7-101, 37-7-201, MCA; NEW, 2002 MAR p. 794, Eff. 2/1/02; AMD, 2006 MAR p. 1615, Eff. 6/23/06.
Home  |   Search  |   About Us  |   Contact Us  |   Help  |   Disclaimer  |   Privacy & Security